{"result": "(\"entity\"<|>HOSPITAL UNIVERSITARIO DOCTOR PESET<|>ORGANIZATION<|>Hospital Universitario Doctor Peset is a medical institution in Valencia where Dr. Christian Salom Vendrell works as a specialist in Endocrinology and Nutrition.)\n##\n(\"entity\"<|>CHRISTIAN SALOM VENDRELL<|>PERSON<|>Dr. Christian Salom Vendrell is a specialist in Endocrinology and Nutrition at Hospital Universitario Doctor Peset in Valencia.)\n##\n(\"entity\"<|>VALENCIA<|>GEO<|>Valencia is a city in Spain where the Hospital Universitario Doctor Peset is located.)\n##\n(\"entity\"<|>CARCINOMA EPIDERMOIDE DE LARINGE<|>EVENT<|>Carcinoma epidermoide de laringe is a type of cancer affecting the larynx, which the patient is diagnosed with.)\n##\n(\"entity\"<|>DIABETES MELLITUS TIPO 2<|>EVENT<|>Diabetes Mellitus tipo 2 is a chronic condition that affects the way the body processes blood sugar (glucose), which the patient has.)\n##\n(\"entity\"<|>GASTROSTOMÍA RADIOLÓGICA PERCUTÁNEA<|>EVENT<|>Gastrostomía radiológica percutánea is a procedure performed on the patient to assist with nutrition due to swallowing difficulties.)\n##\n(\"entity\"<|>LARINGUECTOMÍA TOTAL<|>EVENT<|>Laringuectomía total is a surgical procedure to remove the entire larynx, which the patient underwent.)\n##\n(\"entity\"<|>RADIOTERAPIA<|>EVENT<|>Radioterapia is a treatment method using radiation, which the patient received after the laryngeal surgery.)\n##\n(\"relationship\"<|>CHRISTIAN SALOM VENDRELL<|>HOSPITAL UNIVERSITARIO DOCTOR PESET<|>Dr. Christian Salom Vendrell works at Hospital Universitario Doctor Peset as a specialist in Endocrinology and Nutrition<|>9)\n##\n(\"relationship\"<|>CARCINOMA EPIDERMOIDE DE LARINGE<|>DIABETES MELLITUS TIPO 2<|>The patient has both carcinoma epidermoide de laringe and diabetes mellitus tipo 2, indicating a complex medical condition<|>4)\n##\n(\"relationship\"<|>CARCINOMA EPIDERMOIDE DE LARINGE<|>GASTROSTOMÍA RADIOLÓGICA PERCUTÁNEA<|>The patient underwent gastrostomía radiológica percutánea due to complications from carcinoma epidermoide de laringe<|>6)\n##\n(\"relationship\"<|>LARINGUECTOMÍA TOTAL<|>CARCINOMA EPIDERMOIDE DE LARINGE<|>The patient underwent laringuectomía total as a treatment for carcinoma epidermoide de laringe<|>8)\n##\n(\"relationship\"<|>RADIOTERAPIA<|>CARCINOMA EPIDERMOIDE DE LARINGE<|>The patient received radioterapia as part of the treatment for carcinoma epidermoide de laringe<|>8)\n##\n(\"relationship\"<|>DIABETES MELLITUS TIPO 2<|>GASTROSTOMÍA RADIOLÓGICA PERCUTÁNEA<|>The patient requires nutritional support through gastrostomía radiológica percutánea due to diabetes mellitus tipo 2<|>5)\n##\n(\"relationship\"<|>RADIOTERAPIA<|>GASTROSTOMÍA RADIOLÓGICA PERCUTÁNEA<|>The patient had to resume gastrostomía radiológica percutánea due to the effects of radioterapia<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: errano P et al. Recommenda-\n     tions of the GARIN group for managing non-critically ill patients with diabetes or stress hyperglycae-\n     mia and artificial nutrition. Nutr Hosp. 2012;27(5):1837-1849.\n\n\n\n     6.  Pironi L, Arends J et al. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr.\n     2016;35(2):247-307.\n\n\n\n     7. Klek S, Forbes A, Gabe S et al. Management of acute intestinal failure: A position paper from the\n     European Society for Clinical Nutrition and Metabolism (ESPEN) Special Interest Group. Clinical Nu-\n     trition. 2016;35(6):1209–1218.\n\n\n\n     8. McClave SA, Martindale RG et al. Guidelines for the Provision and Assessment of Nutrition Support\n     Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American So-\n     ciety for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2009;33(3):260-76.\n\n\n\n     9.  McMahon MM, Nystrom E et al. A.S.P.E.N. clinical guidelines: nutrition support of adult patients\n     with hyperglycemia. JPEN J Parenter Enteral Nutr. 2013;37(1):23-36.\n\n\n\n     10. Olveira G, García-Luna PP, Pereira JL, Rebollo I, García-Almeida JM, Serrano P et al. Recommenda-\n     tions of the GARIN group for managing non-critically ill patients with diabetes or stress hyperglycae-\n     mia and artificial nutrition. Nutr Hosp. 2012;27(5):1837-1849.\n\n\n\n     11. Mary T. Korytkowski, MD, Rose J. Salata, MD et al. Insulin Therapy and Glycemic Control in Hospi-\n     talized Patients With Diabetes During Enteral Nutrition Therapy. Diabetes Care. 2009; 32(4): 594-596.\n\n\n\n     12. Bharati Kochar, Hans H. Herfarth et al. Teduglutide for the treatment of short bowel syndrome – a\n     safety evaluation. Expert Opinion on Drug Safety. 2018;17:7, 733-739.\n\n\n\n     13.   Douglas L. Seidner et al. Reduction of Parenteral Nutrition and Hydration Support and Safety\n     With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome Associated Intestinal\n     Failure: STEPS-3 Study. Nutrition in Clinical Practice. 2018; 33(4), 520–527.\n\n\n\n136\n---\n   Caso Clínico\nNutrición enteral en paciente diabético con\ncarcinoma epidermoide de laringe\nDr. Christian Salom Vendrell\nMédico Especialista en Endocrinología y Nutrición.\nHospital Universitario Doctor Peset, Valencia.\n\n\n\nResumen\n         Paciente varón de 66 años con carcinoma epidermoide de laringe y portador de\ngastrostomía radiológica percutánea (GRP) previo al tratamiento: laringuectomía total\n(LT), vaciamiento funcional derecho y radioterapia (RT).\n\n\n\n         El resto de los antecedentes del paciente son Diabetes                  Mellitus (DM) tipo 2 en\ntratamiento con insulina, dislipemia e hipertensión arterial.\n\n\n\n         Durante el ingreso para la LT, se consulta con la Unidad de Nutrición (UN) para\najuste de la nutrición enteral (NE) por la GRP e insulínico. En dicho momento, el pacien-\nte estaba en riesgo nutricional, sin desnutrición establecida y con afagia debido a la\nintervención.\n\n\n\n         Durante los 7 primeros días tras la intervención, el paciente estuvo con NE con\nfórmula inmunomoduladora y posteriormente hasta el alta con fórmula de NE específi-\nca para DM. Se ajustó, durante el ingreso, el tratamiento insulínico. En el momento del\nalta, tras 18 días de ingreso y 10 kg de pérdida de peso, el paciente había recuperado la\ndeglución, con ingesta oral de dieta túrmix disfagia que cubrían sus requerimientos. Se\nmantuvo la GRP ya que iba a recibir RT.\n\n\n\n         En consultas externas (CCEE) debido al déficit de ingesta por la mucositis se-\ncundaria a la RT, se pauta de nuevo NE para DM por la GRP. Una vez finalizada la RT, el\npaciente recupera la ingesta, manteniéndose con dieta túrmix disfagia y suplementos\nnutricionales orales (SNO) hasta la actualidad, en el que no hay recidiva de la neopla-\nsia, por lo que se ha retirado la GRP y sigue controles en CCEE.\n\n\n\nPalabras clave\n         Carcinoma epidermoide de laringe, diabetesmellitus tipo 2, gastrostomía radio-\nlógica percutánea, radioterapia, laringuectomía total, desnutrición, riesgo nutricional,\ninmunonutrición,\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}